Furthermore, another report demonstrated that conditioned medium from cancer-reprogrammed fibroblasts more effectively limits the therapeutic efficacy of HER2 kinase blockade compared to conditioned medium from tumor-naïve fibroblasts [41]. This evidence concerns the gene ERBB2 and neoplasm.